Meta-analysis of cannabinoid ligand binding affinity and receptor distribution: interspecies differences.

Area of Science:

• Pharmacology and Neuroscience
• Receptor Binding Assays
• Meta-Analysis Methodologies

Background:

• Cannabinoid receptors (CB1 and CB2) are crucial targets for therapeutic interventions.
• Understanding ligand binding affinities is essential for drug development.
• Previous studies on cannabinoid receptor binding show considerable variability.

Purpose of the Study:

• To synthesize existing data on ligand binding affinities at human (Hs) and rat (Rn) CB1 and CB2 receptors.
• To identify and correct for sources of data heterogeneity in binding studies.
• To establish the most valid estimates of binding affinities and analyze interspecies differences.

Main Methods:

• Meta-analysis of data from 211 studies measuring ligand binding affinities.
• Modified Cochrane methods adapted for non-clinical data analysis.
• Meta-regression to identify sources of heterogeneity (e.g., tissue type, radioligand).

Main Results:

• Significant differences in Ki values for delta 9-tetrahydrocannabinol between HsCB1 and RnCB1.
• Significant differences in Kd values for CP55,940 and WIN55,212-2 across HsCB1, RnCB1, and HsCB2.
• Denser HsCB1 expression in cognitive brain regions compared to RnCB1 in movement-associated areas.

Conclusions:

• The study provides the most valid estimates of Kd and Ki values for key cannabinoid receptor ligands.
• Significant interspecies differences exist in cannabinoid receptor binding affinities and brain distribution.
• Methodological factors significantly contribute to data heterogeneity in binding studies.